




An informatics approach to monitor the coverage of antibiotic regimens using open-
source software






Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Holten, V., & Schønheyder, H. C. (2017). An informatics approach to monitor the coverage of antibiotic regimens
using open-source software. Poster presented at 27th European Congress of Clinical Microbiology and
Infectious Diseases (ECCMID), Vienna, Austria.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Downloaded from vbn.aau.dk on: August 24, 2021
An informatics approach to monitor the coverage of antibiotic regimens using open-source software
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Introduction
Antibiotic stewardship programs (ASPs) are important local 
countermeasures to the global problem of antibiotic resistance. 
An ASP can reserve broad-spectrum antibiotics for patients 
most in need of effective treatment or prophylaxis. Current 
recommendations for ASPs emphasize collaboration with 
departments of clinical microbiology to keep guidelines up-
to-date with prevalence of antibiotic resistance. However, 
antibiotic susceptibility testing (AST) primarily serves the 
need of the individual patient, and there may be addition-
al constrains. Therefore, AST data can be cumbersome to 
apply to ASP purposes. A syndromic approach have been 
suggested (1). We describe here an informatics approach 
to monitor the coverage of various empirical antibiotic reg-
imens using open source software.
Results
First we assessed the time window for exclusion of repeat iso-
lates. We found a distinct threshold when selecting a 5-day 
period, and subsequently this interval was used. During the 
5-year period 10,267 blood isolates were retrieved including 
1,305 repeat isolates resulting in 8,962 unique isolates. We 
analyzed 8 antibiotic regimens (Table). Notably, CR-ALGO 
included information from approximately 50% more isolates 
than CR-AST and showed the combination of ampicillin, 
gentamicin and metronidazole to be comparable with pip-
eracillin/tazobactam in combination with gentamicin and 
even with meropenem monotherapy. Three antibiotic reg-
imens were used in an analysis stratified by departments. 
The figure depicts the coverage of the three regimens during 
the years 2011-2015. A decrease in coverage in 2013 was 
followed by an increase during 2014-2015 as shown by all 
three indicators.
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Conclusions
Implementation of algorithms augments 
• consistency in monitoring coverage
•  shows promise for antibiotic stewardship programs
• should be adaptable to other speciemen types
Methods
We obtained AST data (SIR classification according to 
EUCAST) for all blood culture isolates deemed clinically 
significant from 2011 through 2015 in North Denmark 
Region (population app. 650,000 inhabitants). Data was 
anonymized keeping information on the time sequence of 
isolates in individual patients. 
The following tasks were implemented by use of algorithms 
in the following order: 
• expert rules for intrinsic resistance
•  inference from an antibiotic tested to other members of 
the class if appropriate for the species
•  exclusion of repeat isolates with identical antibiogram 
within a given time interval. The interval was selected 
based on a graphical analysis (not shown). 
Antibiotic susceptibility was defined by SIR = S, and this rule 
was not relinquished for combination therapy. Coverage was 
calculated by the proportion of susceptible isolates among 
all unique isolates within the time window. 
We report three estimates of coverage based on 
1) AST data (CR-AST), 
2) AST data emended by algorithms (CR-ALGO),
3)  emended AST data, but assuming resistance for an entire 
class if no representative antibiotic was tested (‘worst 
case scenario’) (CR-WCS).
Algorithms were implemented in R (www.r-project.org). 
Algorithm used to apply inference within the beta-lactam anti-
biotic group

























Coverage of antibiotic regimens using CR-AST, CR-ALGO, and CR-WCS





Penicillin & Gentamicin 1809 81.1 1775 82.1 1892 80.4
Ampicillin & Gentamicin 1546 86.9 1767 86.9 1892 84.6
Ampicillin, Gentamicin & 
Metronidazol 1542 91.0 1763 90.5 1892 89.2
Piperacillin/tazobactam 1231 86.6 1809 77.4 1892 74.0
Piperacillin/tazobactam & 
Gentamicin 1196 91.6 1739 90.7 1892 88.5
Cefuroxim & Gentamicin 1777 82.2 1783 83.3 1892 80.5
Meropenem 244 93.9 1823 93.0 1892 89.6
Meropenem & Gentamicin 230 97.4 1753 93.8 1892 91.4









CR-ALGO 220 84.1 208 84.1 222 87.8
CR-WCS 238 83.6 238 80.7 238 81.9
Abdominal 
Surgery
CR-ALGO 176 81.8 168 82.1 176 86.4
CR-WCS 188 81.4 188 79.3 188 80.9
Medicine CR-ALGO 824 89.6 816 89.5 852 91.4
CR-WCS 876 88.1 876 88.0 876 89.0
Hematology CR-ALGO 78 74.4 78 71.8 82 72.0
CR-WCS 84 75.0 84 72.6 84 70.2
Intensive 
Care Unit
CR-ALGO 74 73.0 72 72.2 75 73.3
CR-WCS 79 70.9 79 70.9 79 69.6
